CONFORMATIONAL-ANALYSIS OF 2 ANTI-HIV NUCLEOSIDE ANALOGS 2',3'-DIDEOXY-3'-FLUOROCYTIDINE AND ITS N4-DIMETHYLAMINOMETHYLENE PRODRUG DERIVATIVE

被引:6
作者
CODY, V [1 ]
KALMAN, TI [1 ]
机构
[1] SUNY BUFFALO,SCH PHARM,DEPT MED CHEM,BUFFALO,NY 14260
来源
NUCLEOSIDES & NUCLEOTIDES | 1992年 / 11卷 / 2-4期
基金
美国国家卫生研究院;
关键词
D O I
10.1080/07328319208021737
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Crystal structure analysis of 2',3'-dideoxy-3'-fluorocytidine (1) and its prodrug derivative, N4-dimethylaminomethylene-2',3'-dideoxy-3'-fluorocytidine 2), active anti-HIV nucleoside analogues, reveals that both structures adopt an anti conformation about the glycosyl bond. The furanose ring is C2'-endo for (2) and C2'-endo/C1'-exo and C2'-endo/C3'-exo for the two independent molecules of (1), respectively.
引用
收藏
页码:731 / 738
页数:8
相关论文
共 15 条
[1]
[Anonymous], 1974, INT TABLES XRAY CRYS, VIV
[2]
UNUSUAL STRUCTURAL FEATURES OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF THE HIV (AIDS) VIRUS [J].
BIRNBAUM, GI ;
LIN, TS ;
PRUSOFF, WH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (01) :608-614
[3]
USE OF NEGATIVE QUARTET COSINE INVARIANTS AS A PHASING FIGURE OF MERIT - NQEST [J].
DETITTA, GT ;
EDMONDS, JW ;
LANGS, DA ;
HAUPTMAN, H .
ACTA CRYSTALLOGRAPHICA SECTION A, 1975, 31 (JUL1) :472-479
[4]
STRUCTURE OF THE MODIFIED NUCLEOSIDE 2',3'-DIDEOXY-3'-FLUOROCYTIDINE [J].
DEWINTER, HL ;
BLATON, NM ;
PEETERS, OM ;
DERANTER, CJ ;
VANAERSCHOT, A ;
HERDEWIJN, P .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1991, 47 :832-835
[5]
APPLICATION OF PHASE RELATIONSHIPS TO COMPLEX STRUCTURES .3. OPTIMUM USE OF PHASE RELATIONSHIPS [J].
GERMAIN, G ;
MAIN, P ;
WOOLFSON, MM .
ACTA CRYSTALLOGRAPHICA SECTION A-CRYSTAL PHYSICS DIFFRACTION THEORETICAL AND GENERAL CRYSTALLOGRAPHY, 1971, A 27 (JUL1) :368-&
[6]
3'-SUBSTITUTED 2',3'-DIDEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTI-HIV (HTLV-III/LAV) AGENTS [J].
HERDEWIJN, P ;
BALZARINI, J ;
DECLERCQ, E ;
PAUWELS, R ;
BABA, M ;
BRODER, S ;
VANDERHAEGHE, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (08) :1270-1278
[7]
HERDEWIJN PAM, 1991, MED CHEM RES, V1, P9
[8]
KALMAN T I, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P409
[9]
KALMAN TI, 1990, ANN NY ACAD SCI, V616, P540
[10]
KALMAN TI, 1990, ANN NY ACAD SCI, V616, P538